|
S2505
|
Rosiglitazone maleate |
Rosiglitazone maleate (Avandia) is an anti-diabetic agent in the thiazolidinedione class of agents. |
|
|
|
S2915
|
GW9662 |
GW9662 is a selective PPAR antagonist, inhibiting PPARγ, PPARα and PPARδ with IC50 of 3.3 nM, 32 nM and 2 μM, respectively. |
|
|
|
S2556
|
Rosiglitazone (Avandia) |
Rosiglitazone (Avandia) is a potent antihyperglycemic agent and a potent thiazolidinedione insulin sensitizer with IC50 of 12, 4 and 9 nM for rat, 3T3-L1 and human adipocytes, respectively. |
|
|
|
S2871
|
T0070907 |
T0070907 is a potent and selective PPARγ inhibitor with IC50 of 1 nM. |
|
|
|
S1473
|
GW501516 |
GW501516 is a selective PPARδ agonist with Ki of 1.1 nM. |
|
|
|
S8029
|
WY 14643 (Pirinixic Acid) |
WY 14643 (Pirinixic Acid) is a potent peroxisome proliferator and activator of PPAR alpha. |
|
|
|
S8026
|
GSK0660 |
GSK0660 is a selective PPARδ antagonist with IC50 of 155 nM. |
|
|
|
S8046
|
GW7647 |
GW7647 is a potent and highly selective PPARα agonist with EC50 of 6 nM. |
|
|
|
S8020
|
GW0742 |
GW0742 is a potent and highly selective PPARβ/δ agonist, binding to hPPARδ with IC50 of 1 nM. |
|
|
|
S2665
|
Ciprofibrate |
Ciprofibrate is a peroxisome proliferator-activated receptor agonist. |
|
|
|
S2075
|
Rosiglitazone HCl |
Rosiglitazone is a blood glucose-lowering drugs, stimulating insulin secretion by binding to the PPAR receptors in fat cells.
|
|
|
|
S2798
|
GW6471 |
GW6471 is an inhibitor of PPARα with IC50 of 0.24 μM. |
|
|